Today: 2 May 2026
Mastercard stock slides as Trump credit-card rate cap talk keeps pressure on MA
14 January 2026
2 mins read

Mastercard stock slides as Trump credit-card rate cap talk keeps pressure on MA

New York, January 13, 2026, 17:40 EST — After-hours

  • Mastercard shares dropped roughly 3.8% Tuesday, following a wider slump in card and bank stocks
  • Investors are digesting the impact of a proposed one-year 10% cap on credit-card interest rates
  • Mastercard will release its quarterly earnings on Jan. 29

Shares of Mastercard dropped 3.8% on Tuesday, slipping further to $544.99 in after-hours trades. The decline came amid investor concerns over President Donald Trump’s plan to limit credit-card interest rates. Visa also took a hit, falling 4.5% during the regular session.

The policy threat arrives at a tricky time for markets. Big banks are reporting earnings this week, while traders scramble to figure out how a rate cap might affect credit availability and consumer spending.

The cap on annual percentage rates, or APRs, targets banks that issue cards, not the payment networks. Investors worry that issuers might respond by cutting credit limits or shutting accounts, which could reduce transaction volumes and hit Mastercard’s fee income.

JPMorgan Chief Financial Officer Jeremy Barnum warned the proposal would be “very bad for consumers, very bad for the economy,” adding the bank would need to scale back the credit it provides. Barnum noted the move is developing “very quickly” and “starting with a social media post,” as Trump also backed reducing card swipe fees—the charges merchants pay to accept cards. Reuters

Credit card debt stacks up quickly since it’s “revolving credit,” allowing balances to roll over each month with interest adding on if only minimum payments are made. U.S. credit card balances hit $1.23 trillion by the end of Q3, according to Reuters. Reuters

Some investors doubt the politics will progress much further. UBS analysts pointed out that implementing rate caps would require an Act of Congress, warning that an executive order would probably face intense legal battles. Still, the uncertainty has weighed on financial stocks.

Analyst opinions are beginning to diverge. Compass Point upgraded Mastercard from Neutral to Buy, lifting its price target to $735 from $620. The firm cited a potential sector rebound following fourth-quarter results.

Mizuho’s Dan Dolev and analysts at Morgan Stanley suggested the impact on card networks may not be as severe as initially thought. Dolev highlighted a potential move toward debit cards and “buy now, pay later” options, both of which still bring in fee income. Barron’s

Mastercard announced it will report its fourth-quarter and full-year 2025 earnings on Jan. 29, with a conference call scheduled for 9:00 a.m. Eastern.

Separately, Mastercard announced a collaboration with travel platform Agoda to develop a loyalty redemption tool. This tool integrates Agoda’s travel inventory into Mastercard’s Global Redemption Suite, offering cardholders greater flexibility in using their points.

Washington remains the key wildcard. Should the rate cap gain momentum—or if swipe fee cuts move from chatter to law—lenders might overhaul card economics, impacting spending, rewards, and network fees. If those efforts falter, the sector’s steep selloff could reverse just as fast.

Next in focus: any updates from the White House or Congress before the proposed Jan. 20 start date, plus Mastercard’s Jan. 29 earnings report for insights on holiday shopping and cross-border payment patterns.

Stock Market Today

  • Truist Financial Raises Amgen Price Target Slightly to $327 with Hold Rating
    May 2, 2026, 8:31 AM EDT. Truist Financial modestly increased its price target for Amgen (NASDAQ:AMGN) to $327 from $325, maintaining a "hold" rating on the biotech giant, reflecting a slight downside potential of 0.43% from the latest close. Other analysts showed mixed views: Goldman Sachs upgraded Amgen to "buy" and raised its target to $425, while Deutsche Bank and Barclays assigned "hold" and "equal weight" ratings with targets around $295-$350. Amgen's recent quarterly earnings impressed with EPS of $5.15 surpassing estimates, and revenue growth of 5.8%. The company expects FY 2026 EPS between 21.7 and 23.1. With a market cap of $177.24 billion and a stable PE ratio of 23.07, Amgen's consensus remains "hold" with an average target near $358, underscoring cautious optimism amid sector challenges.

Latest article

Beyond ChatGPT And Nvidia: 3 Technologies Wall Street May Have To Reprice Before 2026 Ends

Beyond ChatGPT And Nvidia: 3 Technologies Wall Street May Have To Reprice Before 2026 Ends

2 May 2026
The S&P 500 and Nasdaq closed at record highs Friday as Alphabet, Amazon, Meta, and Microsoft projected 2026 AI spending above $700 billion. Meta shares dropped nearly 10% after raising its capital-spending outlook, while Alphabet rose on strong Google Cloud revenue. Meta acquired Assured Robot Intelligence, expanding into robotics AI. Google began selling its AI chips directly to customers, challenging Nvidia.
Forget Big Tech: Data Storage Stocks Are Becoming AI’s Quiet Market Dark Horse

Forget Big Tech: Data Storage Stocks Are Becoming AI’s Quiet Market Dark Horse

2 May 2026
Seagate shares rose 7.9% and Sandisk jumped 8.3% Friday, while Western Digital slipped 0.6%. Sandisk reported Q3 revenue up 251% to $5.95 billion and signed $42 billion in long-term supply deals. Western Digital’s Q3 revenue climbed 45% to $3.34 billion, topping analyst estimates. Seagate forecast Q4 revenue of $3.45 billion, citing AI-driven demand.
Palantir stock (PLTR) slips after hours as Feb. 2 earnings date set and Citi turns bullish
Previous Story

Palantir stock (PLTR) slips after hours as Feb. 2 earnings date set and Citi turns bullish

Strategy (MSTR) stock jumps after-hours after $1.25 billion bitcoin buy
Next Story

Strategy (MSTR) stock jumps after-hours after $1.25 billion bitcoin buy

Go toTop